Sunday, November 13, 2016
- 9:00AM-11:00AM
-
Abstract Number: 775
Evaluation of Use of Belimumab in Clinical Practice Settings: Results in Argentina
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster I: Clinical Trial Design and Current Therapies- 9:00AM-11:00AM
-
Abstract Number: 373
Evidence for TMJ Pain As a Component of a Generalized Pain Phenotype
Pain – Basic and Clinical Aspects - Poster- 9:00AM-11:00AM
-
Abstract Number: 535
Examination of Diurnal and Daily Variation of the Multi-Biomarker Disease Activity (MBDA) Score in RA to Establish the Minimally Important Difference
Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis- 9:00AM-11:00AM
-
Abstract Number: 208
Examination of Serum Uric Acid (sUA) Lowering and Safety with Extended Lesinurad + Allopurinol Treatment in Subjects with Gout
Metabolic and Crystal Arthropathies - Poster I: Clinical Practice- 9:00AM-11:00AM
-
Abstract Number: 826
Exercise Echocardiography Predicts Future Development of Pulmonary Hypertension in a High-Risk Cohort of Scleroderma Patients
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster I- 9:00AM-11:00AM
-
Abstract Number: 329
Explore the Possible Mechanisms of 1,25(OH)2D3 on the Formation of Osteoclasts in Rheumatoid Arthritis
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster- 9:00AM-11:00AM
-
Abstract Number: 488
Exploring the Association Between Air Pollutant Exposure and Seropositivity in Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis- 9:00AM-11:00AM
-
Abstract Number: 643
Exposure-Response Analyses of Efficacy of ABT-122, a Dual-Variable Domain Immunoglobulin (DVD-Ig™) Targeting TNF-α and IL-17A, Compared with Adalimumab in Subjects with Rheumatoid Arthritis and Background MTX
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster I- 9:00AM-11:00AM
-
Abstract Number: 761
Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster I: Clinical Trial Design and Current Therapies- 9:00AM-11:00AM
-
Abstract Number: 874
Expression and Function of IL-12/23 Related Cytokine Subunits (p35, p40 and p19) in Giant-Cell Arteritis Lesions. Potential Role of p40 in Promoting Th1 -Mediated Pathways
Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 278
Expression of Anti-Microbial Peptide LL-37 Correlates to the Activation of Type I Interferon Pathway in Patients with Idiopathic Inflammatory Myopathies
Muscle Biology, Myositis and Myopathies - Poster I: Basic/Translational- 9:00AM-11:00AM
-
Abstract Number: 660
Expression of the Chemokine Receptor CXCR5 Is Decreased in the Periphery of Patients with Primary Sjogren’s Syndrome
Sjögren's Syndrome - Poster I: Translational Science- 9:00AM-11:00AM
-
Abstract Number: 657
Expression of Type-III Interferons (IFNλs) and Their Receptor in Sjögren’s Syndrome
Sjögren's Syndrome - Poster I: Translational Science- 9:00AM-11:00AM
-
Abstract Number: 283
Extracellular Histidyl-tRNA Synthetase in Myositis
Muscle Biology, Myositis and Myopathies - Poster I: Basic/Translational- 9:00AM-11:00AM
-
Abstract Number: 820
EZH2 Modulates Angiogenesis and Fibrosis in Scleroderma